[ad_1] Notice of great interest for the C.OVID developed by company AstraZeneca together with the University of Oxford. The vaccine could become available for use in late December, the pharmaceutical manufacturer’s chief executive said. The company is now awaiting approval from regulatory authorities in the drug market. The vaccine developed …
Read More »Why is the Oxford-AstraZeneca vaccine easier to use than others currently being tested? An explanation from the doctor
